Tilray Brands, Inc. TLRY

Tilray Brands - German Cannabis Legalization Update

[DaveInCalgary]

By Far the LARGEST positive law change in Germany for Aphria/Tilray was the announcement that Medical Cannabis was being De-Scheduled and No Longer classified as a Narcotics as of January 1, 2024.

Aphria/Tilray hold 40% of the German Government issued medical cannabis licenses.

Aphria/Tilray was the only company to be allowed to grow all 3 Medical Cannabis Strains approved by the German Government.

German government know DEMAND with far exceed IN COUNTRY SUPPLY, and issued Aphria/Tilray a BiLateral Agreement to also supply Medical Cannabis from Canada.

Aphria/Tilray already have approved plans in place to build out their German Facilities, but that will take a couple of years.
 

Medical cannabis - Q&A - Germany Jan 1, 2024

41. Will Medical cannabis still be available in a Pharmacies with a Prescription?

• Yes. Medical cannabis should be legally clearly separated from cannabis for non-medical purposes. Medical cannabis is therefore not regulated in the Cannabis Act, but in a separate Medical Cannabis Act. The content of the existing regulations on medical cannabis remains essentially unchanged. Medical cannabis may continue to be prescribed as a medicine in accordance with the applicable social law requirements. However, a prescription for a special narcotic prescription will no longer be necessary in the future. A regular recipe is sufficient here.
  
  42. Does the law Now Allow Any Company To Grow Medical Cannabis

• No. The cultivation of cannabis continues to be carried out by companies that were selected in a Europe-wide tender process and commissioned by the Cannabis Agency at the Federal Institute for Drugs and Medical Devices. This cannabis is grown exclusively for medical purposes in accordance with pharmaceutical quality requirements. The prescription requirement remains.

https://www.bundesgesundheitsministerium.de/themen/cannabis/faq-cannabisgesetz-entwurf.html